(NASDAQ: CERS) Cerus's forecast annual revenue growth rate of 5.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.14%.
Cerus's revenue in 2025 is $216,389,000.On average, 6 Wall Street analysts forecast CERS's revenue for 2025 to be $41,146,229,144, with the lowest CERS revenue forecast at $37,572,963,624, and the highest CERS revenue forecast at $46,255,002,004. On average, 6 Wall Street analysts forecast CERS's revenue for 2026 to be $46,097,808,993, with the lowest CERS revenue forecast at $41,142,395,168, and the highest CERS revenue forecast at $50,804,014,386.
In 2027, CERS is forecast to generate $51,963,792,090 in revenue, with the lowest revenue forecast at $48,844,852,711 and the highest revenue forecast at $54,649,492,194.